Cranford Hospice is Hawke's Bay's leading palliative care provider. Our dedicated team is available 24 hours a day, seven days a week.
---------------------------
AXA
axaglobalhealthcare.com
Go further with international health insurance. Global support for people who think a little bigger
---------------------------
APOLLONIO
apollonion.com
The Apollonion Private Hospital is an ultra-modern Hospital purposely built to offer the best medical care to its patients.
---------------------------
Durbin
durbinglobal.com
Specialist medical suppliers in sourcing and distributing pharmaceuticals, medical equipment and consumable supplies.
---------------------------
Self
self.com
Women Magazine on Fitness, Health, Food, Beauty & more.
---------------------------
Easyway
allencarr.com
Allen Carr Easyway International operates clinics in more than 150 cities in over 50 countries worldwide.
---------------------------
id Hospital
idhospital.com
All kinds of plastic surgeries at affordable cost.
---------------------------
Al Zahra Hospital
alzahra.com
Al Zahra Hospital Sharjah is the first and the largest private general hospital in the UAE with both inpatient and outpatient treatment at an international standard,
---------------------------
Kunming Children�s Hospital
crhealthcare.com.hk
Kunming Children Hospital integrates first aid, medical treatment, rehabilitation, health care, & scientific research.
---------------------------
UT Health
uthealtheasttexas.com
UT Health East Texas is passionate about delivering the highest quality care with unmatched compassion, outstanding service and innovative technology.
---------------------------
WORLD HOSPITAL DIRECTORY
WHD International Journal of Medical & Health Science
Author and Copyrights: Dr Mariappa Babu Baskar @ World Hospital Directory
Title:
Acne: Asthma Drug Fails to Help Patients with Acne
Word Count:
245
Summary:
The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.
Keywords:
acne treatments
Article Body:
The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.
Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos � far short of achieving statistical significance.
Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.
The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.
Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent "proof of concept" trial.
The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.
Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO). It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.
Home
Contact
Back to "WHD International Journal of Medical & Health Science- Homepage"
